A popular weight loss drug reduced the risk of COVID-19 deaths, according to a new study. The research, published Friday in the Journal of the American College of Cardiology, found during a clinical trial of Wegovy that people taking the obesity drug during the COVID pandemic were less likely to die from the virus. Semaglutide,...
Hundreds possibly exposed to rabies in bat-infested cabins at Wyoming national park
- yesterday, 10:40 PM
- nbcwashington.com
- 0
No comments